Clinical trialNCT02532452RecruitingPhase 2Interventional

Third Party Viral Specific T-cells (VSTs)

SponsorChildren's Hospital Medical Center, CincinnatiEnrollment750Infection in an Immunocompromised HostViral InfectionViral Reactivation

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to demonstrate that viral specific T-cells (a type of white blood cell) can be generated from an unrelated donor and given safely to patients with viral infections.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Michael Grimley, MD, MD
Children's Hospital Medical Center, Cincinnati
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Akron Children'S Hospital
Akron, Ohio, United States
Megan Sampson, MD
Recruiting
Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
Michael Grimley, MD
Recruiting
University of Cincinnati Medical Center
Cincinnati, Ohio, United States
Completed
the Ohio State University Wexner Medical Center - James Cancer Hospital
Columbus, Ohio, United States
Polina Shindiapina, MD, PhD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Viral Specific VST Infusion

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 2 Sept 2015
Primary completion: 31 Dec 2026
Completion: 31 Dec 2027
Last update posted: 16 Dec 2025
Registered enrollment: 750
Registry id: NCT02532452

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.